Sweden has extended its pause of the Moderna COVID-19 vaccine for people aged 30 and younger due to heart-related side-effects, the public health agency announced on Oct. 21.
The European Medicines Agency approved the use of Moderna’s Spikevax for children aged over 12 in July, marking the first time the shot had been authorized for use in people under 18.